Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (67)	11/5/2000 8:04:04 PM
From: tuck	Read Replies (2) \| Respond to of 1784

tom, You had it right. See, all the technicians hired to run the trickle down equipment will make just enough to get an new exhaust system, not a new beemer like their bosses. Wondering what Peter sees in BIOI. Possible turnaround with a couple key managers and some preferred stock retiring? They seem to be trying to expand. Broad catalog of trickle products. Hope they've got the right products. They have good, though declining, margins due to a rise in cost of materials. Expensive for earnings growth, reasonable P/S. biz.yahoo.com On no obvious news I can find, it was up hugely during the spring spike from low single digits to high 30s. Management must have uttered the word "genomics" at some point, eh? Prior to yesterday's bounce the stock has been weak of late. siliconinvestor.com Thoughts, crew? Cheers, Tuck

To: tom pope who wrote (67)	11/10/2000 12:03:51 PM
From: tuck	Read Replies (1) \| Respond to of 1784

tom, OK. MDZ is at 8 1/2 by 8 13/16 RT. B/A 300 X 100. Trickle manager is going to figure the market maker won't mess with him too much and will give him 200 shares for 18 13/16. Cheers, Tuck